Lv3
290 积分 2023-09-24 加入
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
10天前
已完结
Transarterial chemoembolization for unresectable hepatocellular carcinoma: a comparative study between transradial and transfemoral approaches
25天前
已完结
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
27天前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
2个月前
已完结
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab
2个月前
已完结
Economic Evaluation of Sintilimab Plus Bevacizumab Versus Sorafenib as a First-line Treatment for Unresectable Hepatocellular Carcinoma
3个月前
已完结
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives
5个月前
已完结
Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis
5个月前
已完结
Hepatocellular carcinoma in China
6个月前
已完结
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
6个月前
已完结
皖公网安备34019202002308
